º¬Ðß²ÝÊÓÆµ

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • July 2026
  • 181 Pages
  • Global
From
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2026 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
From
From
From
Bioequivalence Studies - Global Strategic Business Report - Product Thumbnail Image

Bioequivalence Studies - Global Strategic Business Report

  • Report
  • July 2026
  • 385 Pages
  • Global
From
From
Obesity Diagnosis & Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Obesity Diagnosis & Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
From
Indonesian Diabetes Devices Market, Forecast to 2023 - Product Thumbnail Image

Indonesian Diabetes Devices Market, Forecast to 2023

  • Report
  • February 2020
  • 72 Pages
  • Indonesia
From
From
Loading Indicator